Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-05

Clinical Trial Update: BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation [NA]

View source ↗

Summary

Completed clinical trial comparing BeEAM versus CEM conditioning regimens in lymphoma patients undergoing autologous hematopoietic cell transplantation; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bendamustine (Bendamustine)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • CYTARABINE (CYTARABINE)
  • Etoposide (Etoposide)
  • Melphalan (Melphalan)

Snippet

Sponsor: Rehab Werida | Conditions: Lymphoma | NA | Status: COMPLETED